APOL1 Genotype, Kidney and Cardiovascular Disease, and Death in Older Adults

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 36, Issue 2, 2016, Pages 398-403

  Mukamal, Kenneth J ^a   Tremaglio, Joseph ^a   Friedman, David J ^a   Ix, Joachim H ^b   Kuller, Lewis H ^c   Tracy, Russell P ^d   Pollak, Martin R ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF VERMONT   (United States)

Author keywords

albuminuria; apolipoproteins; epidemiology; genetics; kidney; myocardial infarction

Indexed keywords

AFRICAN AMERICAN; AGED; ALBUMINURIA; APOLIPOPROTEIN L1 GENE; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; FEMALE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAZARD RATIO; HEART INFARCTION; HOMOZYGOSITY; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; MALE; PRIORITY JOURNAL; TRYPANOSOMIASIS; AGE; CAUCASIAN; CAUSE OF DEATH; CLINICAL TRIAL; COMPARATIVE STUDY; EPIDEMIOLOGY; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; HEALTH DISPARITY; HETEROZYGOTE; HOMOZYGOTE; INCIDENCE; KAPLAN MEIER METHOD; MORTALITY; MULTICENTER STUDY; PHENOTYPE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR; UNITED STATES;

APOL1 PROTEIN, HUMAN; APOLIPOPROTEIN; HIGH DENSITY LIPOPROTEIN;

AFRICAN AMERICANS; AGE FACTORS; AGED; ALBUMINURIA; APOLIPOPROTEINS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEALTH STATUS DISPARITIES; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; KIDNEY DISEASES; LIPOPROTEINS, HDL; MALE; MYOCARDIAL INFARCTION; PHENOTYPE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 84955557772     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.115.305970     Document Type: Article

References (32)

1. Mensah GA, Mokdad AH, Ford ES, Greenlund KJ, Croft JB, State of disparities in cardiovascular health in the United States. Circulation 2005 111 1233 1241. doi: 10.1161/01.CIR.0000158136.76824.04.
2. Ix JH, Allison MA, Denenberg JO, Cushman M, Criqui MH, Novel cardiovascular risk factors do not completely explain the higher prevalence of peripheral arterial disease among African Americans. The San Diego Population Study. J Am Coll Cardiol 2008 51 2347 2354. doi: 10.1016/j.jacc.2008.03.022.
3. Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM, Saydah SH, Williams DE, Geiss LS, Gregg EW, Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care 2006 29 1263 1268. doi: 10.2337/dc06-0062.
4. Halevy D, Radhakrishnan J, Appel GB, Racial and socioeconomic factors in glomerular disease. Semin Nephrol 2001 21 403 410
5. Peralta CA, Ziv E, Katz R, Reiner A, Burchard EG, Fried L, Kwok PY, Psaty B, Shlipak M, African ancestry, socioeconomic status, and kidney function in elderly African Americans: a genetic admixture analysis. J Am Soc Nephrol 2006 17 3491 3496. doi: 10.1681/ASN.2006050493.
6. Kao WH, Klag MJ, Meoni LA, Family Investigation of Nephropathy and Diabetes Research Group MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 2008 40 1185 1192. doi: 10.1038/ng.232.
7. Kopp JB, Smith MW, Nelson GW, MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 2008 40 1175 1184. doi: 10.1038/ng.226.
8. Genovese G, Friedman DJ, Ross MD, Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010 329 841 845. doi: 10.1126/science.1193032.
9. Kopp JB, Nelson GW, Sampath K, APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 2011 22 2129 2137. doi: 10.1681/ASN.2011040388.
10. Tzur S, Rosset S, Shemer R, Yudkovsky G, Selig S, Tarekegn A, Bekele E, Bradman N, Wasser WG, Behar DM, Skorecki K, Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet 2010 128 345 350. doi: 10.1007/s00439-010-0861-0.
11. Genovese G, Friedman DJ, Pollak MR, APOL1 variants and kidney disease in people of recent African ancestry. Nat Rev Nephrol 2013 9 240 244. doi: 10.1038/nrneph.2013.34.
12. Friedman DJ, Kozlitina J, Genovese G, Jog P, Pollak MR, Population-based risk assessment of APOL1 on renal disease. J Am Soc Nephrol 2011 22 2098 2105. doi: 10.1681/ASN.2011050519.
13. Parsa A, Kao WH, Xie D, AASK Study Investigators; CRIC Study Investigators APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med 2013 369 2183 2196. doi: 10.1056/NEJMoa1310345.
14. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C, Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005 352 2049 2060. doi: 10.1056/NEJMoa043161.
15. Cao JJ, Biggs ML, Barzilay J, Konen J, Psaty BM, Kuller L, Bleyer AJ, Olson J, Wexler J, Summerson J, Cushman M, Cardiovascular and mortality risk prediction and stratification using urinary albumin excretion in older adults ages 68-102: the Cardiovascular Health Study. Atherosclerosis 2008 197 806 813. doi: 10.1016/j.atherosclerosis.2007.07.029.
16. Cao JJ, Barzilay JI, Peterson D, Manolio TA, Psaty BM, Kuller L, Wexler J, Bleyer AJ, Cushman M, The association of microalbuminuria with clinical cardiovascular disease and subclinical atherosclerosis in the elderly: the Cardiovascular Health Study. Atherosclerosis 2006 187 372 377. doi: 10.1016/j.atherosclerosis.2005.09.015.
17. Fung ET, Wilson AM, Zhang F, Harris N, Edwards KA, Olin JW, Cooke JP, A biomarker panel for peripheral arterial disease. Vasc Med 2008 13 217 224. doi: 10.1177/1358863X08089276.
18. Ito K, Bick AG, Flannick J, Increased burden of cardiovascular disease in carriers of APOL1 genetic variants. Circ Res 2014 114 845 850. doi: 10.1161/CIRCRESAHA.114.302347.
19. Vanhollebeke B, Pays E, The trypanolytic factor of human serum: many ways to enter the parasite, a single way to kill. Mol Microbiol 2010 76 806 814. doi: 10.1111/j.1365-2958.2010.07156.x.
20. Pays E, Vanhollebeke B, Vanhamme L, Paturiaux-Hanocq F, Nolan DP, Pérez-Morga D, The trypanolytic factor of human serum. Nat Rev Microbiol 2006 4 477 486. doi: 10.1038/nrmicro1428.
21. Lecordier L, Vanhollebeke B, Poelvoorde P, Tebabi P, Paturiaux-Hanocq F, Andris F, Lins L, Pays E, C-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense. PLoS Pathog 2009 5 e1000685. doi: 10.1371/journal.ppat.1000685.
22. Matemba LE, Fèvre EM, Kibona SN, Picozzi K, Cleaveland S, Shaw AP, Welburn SC, Quantifying the burden of rhodesiense sleeping sickness in Urambo District, Tanzania. PLoS Negl Trop Dis 2010 4 e868. doi: 10.1371/journal.pntd.0000868.
23. Richer J, Chudley AE, The hemoglobinopathies and malaria. Clin Genet 2005 68 332 336. doi: 10.1111/j.1399-0004.2005.00503.x.
24. Kanji Z, Powe CE, Wenger JB, Genetic variation in APOL1 associates with younger age at hemodialysis initiation. J Am Soc Nephrol 2011 22 2091 2097. doi: 10.1681/ASN.2010121234.
25. Bentley AR, Doumatey AP, Chen G, Variation in APOL1 contributes to ancestry-level differences in HDLc-kidney function association. Int J Nephrol 2012 2012 748984. doi: 10.1155/2012/748984.
26. Kessler T, Erdmann J, Schunkert H, Genetics of coronary artery disease and myocardial infarction-2013. Curr Cardiol Rep 2013 15 368. doi: 10.1007/s11886-013-0368-0.
27. Böger CA, Chen MH, Tin A, CKDGen Consortium CUBN is a gene locus for albuminuria. J Am Soc Nephrol 2011 22 555 570. doi: 10.1681/ASN.2010060598.
28. Manolio TA, Burke GL, Psaty BM, Newman AB, Haan M, Powe N, Tracy RP, O'Leary DH, Black-white differences in subclinical cardiovascular disease among older adults: the Cardiovascular Health Study. CHS Collaborative Research Group. J Clin Epidemiol 1995 48 1141 1152
29. Kelley E, Moy E, Stryer D, Burstin H, Clancy C, The national healthcare quality and disparities reports: an overview. Med Care 2005 43 3 suppl I3 I8
30. Hauck FR, Tanabe KO, Moon RY, Racial and ethnic disparities in infant mortality. Semin Perinatol 2011 35 209 220. doi: 10.1053/j.semperi.2011.02.018.
31. Hennekens CH, Drowos J, Levine RS, Mortality from homicide among young Black men: a new American tragedy. Am J Med 2013 126 282 283. doi: 10.1016/j.amjmed.2012.07.007.
32. Schwartz RS, Racial profiling in medical research. N Engl J Med 2001 344 1392 1393. doi: 10.1056/NEJM200105033441810.